Authors:
BOKEMEYER C
HARSTRICK A
BEYER J
METZNER B
RUTHER U
HARTMANN JT
HOLSTEIN K
DERIGS HG
DEWIT R
CASPER J
SCHOFFSKI P
KUHRER I
ILLIGER HJ
KEMPF B
REICHLE A
FOLLER A
HOSSFELD DK
FISCHER JT
BERDEL W
GERHARTZ H
KIRCHNER H
PFLUGER K
OSTERMANN H
KANZ L
SCHMOLL HJ
Citation: C. Bokemeyer et al., FIRST-LINE HIGH-DOSE CHEMOTHERAPY FOR POOR-RISK METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS, Onkologie, 21, 1998, pp. 23-25
Authors:
GOLDSCHMIDT H
MARTIN H
HEGENBART U
KO Y
GLASMACHER A
GERHARTZ H
HANEL A
RUDOLPH C
WILHELM M
GIESELER F
BORNHAUSER M
EHNINGER G
HOELZER D
HUHN D
HAAS R
Citation: H. Goldschmidt et al., TANDEM AUTOLOGOUS TRANSPLANTATION (TPX) FOR MULTIPLE-MYELOMA - FIRST RESULTS OF A GERMAN MULTICENTER STUDY, Bone marrow transplantation, 21, 1998, pp. 724-724
Authors:
GOLDSCHMIDT H
MARTIN H
SERKE S
HEGENBART U
GLASMACHER A
KO Y
SCHULTZE W
HANEL A
RUDOLPH C
GERHARTZ H
HASTKA J
WILHELM M
GIESELER F
BORNHAUSER M
EHNINGER G
HOELZER D
HUHN D
HAAS R
Citation: H. Goldschmidt et al., TANDEM AUTOLOGOUS TRANSPLANTATION (TPX) FOR MULTIPLE-MYELOMA - RESULTS OF A GERMAN MULTICENTER STUDY, British Journal of Haematology, 102(1), 1998, pp. 353-353
Authors:
LOEFFLER M
DIEHL V
PFREUNDSCHUH M
RUHL U
HASENCLEVER D
NISTERSBACKES H
SIEBER M
TESCH H
FRANKLIN J
GEILEN W
BARTELS H
CARTONI C
DOLKEN G
ENZIAN J
FUCHS R
GASSMANN W
GERHARTZ H
HAGENAUKAMP U
HILLER E
HINKELBEIN H
HINTERBERGER W
KIRCHNER H
KOCH P
KRUGER B
KURTEN H
KUTZNER K
LOOS U
MENDE W
MULLER H
OERTEL W
PETSCH S
PFAB R
PFLUGER H
ROHLOFF R
SAUER R
SCHALK K
SCHICK HD
SCHOPPE W
SZEPESI S
TEICHMANN J
WORST P
FISCHER R
GEORGII A
HUBNER K
SCHWARZE EW
Citation: M. Loeffler et al., DOSE-RESPONSE RELATIONSHIP OF COMPLEMENTARY RADIOTHERAPY FOLLOWING 4 CYCLES OF COMBINATION CHEMOTHERAPY IN INTERMEDIATE-STAGE HODGKINS-DISEASE, Journal of clinical oncology, 15(6), 1997, pp. 2275-2287
Authors:
SONNEVELD P
SUCIU S
WEIJERMANS P
BEKSAC M
NEUWIRTOVA R
SOLBU G
LOKHORST H
VANDERLELIE J
DOHNER H
GERHARTZ H
SEGEREN CM
WILLEMZE R
LOWENBERG B
Citation: P. Sonneveld et al., CYCLOSPORINE-A COMBINED WITH VAD VS VAD IN PATIENTS WITH REFRACTORY MULTIPLE-MYELOMA - AN EORTC HOVON RANDOMIZED PHASE-II STUDY/, Blood, 90(10), 1997, pp. 1590-1590
Authors:
DIEHL V
LOEFFLER M
PFREUNDSCHUH M
RUEHL U
HASENCLEVER D
NISTERSBACKES H
SIEBER M
SMITH K
TESCH H
GEILEN W
ADLER M
BARTELS H
BRANDENBURG U
DIEZLER P
DOELKEN G
ENZIAN J
FUCHS R
GASSMANN W
GERHARTZ H
HAGENAUKAMP U
HECHT T
HILLER E
HINKELBEIN H
LATHAN B
KIRCHNER H
KUEHN G
KUERTEN H
LOOS U
MAKOSKI B
OERTEL W
PETSCH S
PFAB R
PFLUEGER H
PLANKER M
ROHLOFF R
SACK H
SAMANDARI S
SAUER R
SCHALK K
SCHMITZ G
SCHOPPE W
SCHWIEDER G
SZEPESI S
TEICHMANN J
WILHELMY W
WORST P
FISCHER R
GEORGII A
HUEBNER K
SCHWARZE EW
Citation: V. Diehl et al., FURTHER CHEMOTHERAPY VERSUS LOW-DOSE INVOLVED-FIELD RADIOTHERAPY AS CONSOLIDATION OF COMPLETE REMISSION AFTER 6 CYCLES OF ALTERNATING CHEMOTHERAPY IN PATIENTS WITH ADVANCED HODGKINS-DISEASE, Annals of oncology, 6(9), 1995, pp. 901-910
Authors:
OTTINGER H
BELKA C
KOZOLE G
ENGELHARD M
MEUSERS P
PAAR D
METZ KA
LEDER LD
CYRUS C
GNOTH S
GERHARTZ H
HUHN D
SIEGERT W
THIEL E
AYDEMIR U
TINTRUP W
LENNERT K
BRITTINGER G
Citation: H. Ottinger et al., DEEP VENOUS THROMBOSIS AND PULMONARY-ARTERY EMBOLISM IN HIGH-GRADE NON-HODGKINS-LYMPHOMA - INCIDENCE, CAUSES AND PROGNOSTIC RELEVANCE, European journal of haematology, 54(3), 1995, pp. 186-194
Authors:
SCHMETZER H
POLECK B
WALTHER J
DUELL T
MITTERMULLER J
WILMANNS W
GERHARTZ H
Citation: H. Schmetzer et al., CLONALITY ANALYSIS AS INDICATOR FOR RESPONSE TO PATIENTS WITH MYELODYSPLASTIC SYNDROME, Blood, 86(10), 1995, pp. 3192-3192
Authors:
FUCHS R
LOFFLER M
PFREUNDSCHUH M
DOLKEN G
GERHARTZ H
HAGENAUKAMP U
HILLER E
PETSCH S
PFLUGER KH
RUHL U
SMITH K
TEICHMANN K
DIEHL V
Citation: R. Fuchs et al., PROGNOSIS OF HIGH-DOSE CHEMOTHERAPY AUTOLOGOUS BONE-MARROW TRANSPLANTATION CANDIDATES NOT RECEIVING THIS TREATMENT AFTER FAILURE OF PRIMARYTHERAPY OF HODGKINS-DISEASE, Leukemia & lymphoma, 14(1-2), 1994, pp. 79-89
Authors:
ENGELHARD M
GERHARTZ H
BRITTINGER G
ENGERT A
FUCHS R
GEISELER B
GERHARTZ D
HAUNAUSKE AR
HARTLAPP HJ
HUHN D
LUDWIG WD
MEUSERS P
MULLER P
PEES HW
PESCHEL C
RADTKE H
SCHADECKGRESSEL C
SCHLIMOK G
SIEGERT W
SPANN W
TERHARDT E
THIEL E
WILMANNS W
BRANDMAIER R
EHRLICH HJ
FARBER L
PARWARESCH M
TIEMANN M
LENNERT K
Citation: M. Engelhard et al., CYTOKINE EFFICIENCY IN THE TREATMENT OF HIGH-GRADE MALIGNANT NON-HODGKINS-LYMPHOMAS - RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY WITH INTENSIFIED COP-BLAM + - RHGM-CSF/, Annals of oncology, 5, 1994, pp. 190000123-190000125
Authors:
LOEFFLER M
RUHL U
HASENCLEVER D
PFREUNDSCHUH M
KIRCHNER H
EMMINGER H
HILLER E
GERHARTZ H
ROHLOFF R
SCHOPPE W
KURTEN H
PFLUGER H
PFAB R
ADLER M
DUHMKE E
SIEBER M
FRANKLIN J
SMITH K
NISTERSBACKES H
TESCH H
DIEHL V
Citation: M. Loeffler et al., IRRADIATION WITH 20, 30 OR 40 GY IS EQUALLY EFFECTIVE IN NONBULKY AREAS AFTER 2 DOUBLE CYCLES OF COPP-ABVD POLY-CHEMOTHERAPY IN INTERMEDIATE STAGE HODGKINS-DISEASE, Blood, 84(10), 1994, pp. 10000234-10000234